PTC CapEx increased by 14.1% to $2.67M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.9%, from $2.81M to $2.67M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -18.3% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.42M | $13.05M | $3.36M | $2.15M | $4.47M | $9.52M | $9.18M | $3.77M | $5.09M | $5.78M | $4.56M | $3.64M | $1.64M | $4.54M | $2.77M | $2.81M | $1.89M | $3.55M | $2.34M | $2.67M |
| QoQ Change | — | +281.6% | -74.2% | -36.1% | +108.1% | +113.0% | -3.5% | -58.9% | +34.9% | +13.6% | -21.0% | -20.2% | -55.0% | +176.8% | -39.0% | +1.5% | -32.8% | +87.9% | -34.0% | +14.1% |
| YoY Change | — | — | — | — | +30.7% | -27.1% | +173.1% | +75.5% | +13.8% | -39.3% | -50.3% | -3.5% | -67.8% | -21.5% | -39.4% | -22.8% | +15.1% | -21.8% | -15.4% | -4.9% |